Feeds

Congress seeks stem cell side-step

Bills aim to bypass Bush funding ban

  • alert
  • submit to reddit

Bridging the IT gap between rising business demands and ageing tools

Members of Congress yesterday introduced bills which aim to bypass president Bush's restrictions on state-funded stem cell research. Advocates of such research from both major parties said they had "given up on persuading Bush to change his policy". The bills propose that any embryonic stem cell lines should be eligible for federal funding, while providing for close federal monitoring of their use, Reuters reports.

In 2001, Bush issued an executive order "restricting federal funding for stem cell research to only those batches of the cells that existed at the time". It was later discovered that these existing stocks were useless due to contamination with non-human a molecule called N-glycolylneuraminic acid - most likely when they were grown in a lab culture containing animal-derived materials from mice and calf foetuses.

One of the bills' sponsors, California Democratic Senator Dianne Feinstein, explained the need for the proposed legislation: "If the federal government doesn't act, we're going to have a patchwork of state laws - and that's already happening. California, for instance, is launching a $3bn initiative to fund cutting-edge stem cell research. In 2004, New Jersey created a $25m embryonic stem cell research center."

Iowa Democratic Senator Tom Harkin added: "It's now clear that the president's policy offers only false hope to the millions of people across this country who are suffering from diseases that could be cured or treated through stem cell research - diseases like juvenile diabetes, Parkinson's, ALS [amyotrophic lateral sclerosis or Lou Gehrig's disease], and many more."

Feinstein also asserted that she and other senators will introduce a bipartisan bill to back "therapeutic cloning" - or somatic cell nuclear transfer - which produces stem cells directly from a patient. ®

Related stories

UK scientists want £100m stem cell foundation
Scientist looks to clone Little Bo Human
US stem cell research in jeopardy

Mobile application security vulnerability report

More from The Register

next story
Bad back? Show some spine and stop popping paracetamol
Study finds common pain-killer doesn't reduce pain or shorten recovery
Malaysian Airlines flight MH17 claimed lives of HIV/AIDS cure scientists
Researchers, advocates, health workers among those on shot-down plane
World Solar Challenge contender claims new speed record
One charge sees Sunswift travel 500kms at over 100 km/h
Mwa-ha-ha-ha! Eccentric billionaire Musk gets his PRIVATE SPACEPORT
In the Lone Star State, perhaps appropriately enough
SMELL YOU LATER, LOSERS – Dumbo tells rats, dogs... humans
Junk in the trunk? That's what people have
All those new '5G standards'? Here's the science they rely on
Radio professor tells us how wireless will get faster in the real world
The Sun took a day off last week and made NO sunspots
Someone needs to get that lazy star cooking again before things get cold around here
prev story

Whitepapers

Designing a Defense for Mobile Applications
Learn about the various considerations for defending mobile applications - from the application architecture itself to the myriad testing technologies.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Reducing security risks from open source software
Follow a few strategies and your organization can gain the full benefits of open source and the cloud without compromising the security of your applications.
Boost IT visibility and business value
How building a great service catalog relieves pressure points and demonstrates the value of IT service management.
Consolidation: the foundation for IT and business transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.